A detailed history of Grant transactions in Pfizer Inc stock. As of the latest transaction made, Grant holds 20,323 shares of PFE stock, worth $580,424. This represents 0.3% of its overall portfolio holdings.

Number of Shares
20,323
Previous 20,263 0.3%
Holding current value
$580,424
Previous $562,000 1.07%
% of portfolio
0.3%
Previous 0.29%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $1,515 - $1,776
60 Added 0.3%
20,323 $568,000
Q1 2024

Apr 25, 2024

SELL
$25.89 - $29.73 $117,514 - $134,944
-4,539 Reduced 18.3%
20,263 $562,000
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $100,678 - $130,770
-3,853 Reduced 13.45%
24,802 $714,000
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $223,827 - $261,632
-6,975 Reduced 19.58%
28,655 $950,000
Q2 2023

Jul 19, 2023

BUY
$36.12 - $41.79 $6,248 - $7,229
173 Added 0.49%
35,630 $1.31 Million
Q1 2023

May 01, 2023

BUY
$39.39 - $51.28 $2,324 - $3,025
59 Added 0.17%
35,457 $1.45 Million
Q4 2022

Jan 10, 2023

BUY
$41.75 - $54.5 $668 - $872
16 Added 0.05%
35,398 $0
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $93,558 - $114,211
2,138 Added 6.43%
35,382 $1.61 Million
Q2 2022

Jul 20, 2022

BUY
$46.53 - $55.17 $1,349 - $1,599
29 Added 0.09%
33,244 $1.73 Million
Q1 2022

Apr 25, 2022

BUY
$45.75 - $56.69 $384,437 - $476,366
8,403 Added 33.87%
33,215 $1.67 Million
Q4 2021

Jan 13, 2022

BUY
$41.32 - $61.25 $661 - $980
16 Added 0.06%
24,812 $1.41 Million
Q3 2021

Oct 27, 2021

BUY
$39.25 - $50.42 $3,807 - $4,890
97 Added 0.39%
24,796 $1.07 Million
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $3,016 - $3,417
84 Added 0.34%
24,699 $996,000
Q1 2021

May 04, 2021

BUY
$33.49 - $37.77 $1,272 - $1,435
38 Added 0.15%
24,615 $951,000
Q4 2020

Jan 15, 2021

BUY
$33.47 - $42.56 $822,592 - $1.05 Million
24,577 New
24,577 $905,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Grant Portfolio

Follow Grant and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.